Literature DB >> 7954236

Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. The Liver Cancer Study Group of Japan.

.   

Abstract

BACKGROUND: Great progress in the diagnosis and surgical treatment of hepatocellular carcinoma (HCC) has led to an increased number of resectable cases. Much attention has been paid to the factors affecting long term survival of patients with HCC after partial hepatectomy.
METHODS: Survival rates for approximately 5800 patients with HCC registered by the Liver Cancer Study Group of Japan who received partial hepatic resection from January 1, 1982 to December 31, 1989 were calculated relative to 14 clinicopathologic variables. Cox's multivariate analysis and the stepwise method then were performed to determine significant prognostic variables and to investigate the appropriate combination of these variables for predicting prognosis.
RESULTS: The use of Cox's multivariate proportional hazard model indicated that significant prognostic indicators were alpha-fetoprotein level, tumor size, number of tumors, accompanying cirrhosis, age, surgical curability, and portal involvement. The stepwise method showed that the most valuable prognostic factor was portal involvement, followed by number of tumors, alpha-fetoprotein level, tumor size, accompanying cirrhosis, age, and surgical curability. Furthermore, it was found that the best predictive combination of two factors was number of tumors and alpha-fetoprotein level and that the best predictive combination of three factors was the alpha-fetoprotein level, tumor size, and number of tumors.
CONCLUSION: This extensive analysis provides information that can be used to predict the prognosis of patients with HCC after undergoing partial hepatectomy.

Entities:  

Mesh:

Year:  1994        PMID: 7954236     DOI: 10.1002/1097-0142(19941115)74:10<2772::aid-cncr2820741006>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  67 in total

1.  Serum vascular endothelial growth factor is a potential biomarker of metastatic recurrence after curative resection of hepatocellular carcinoma.

Authors:  Qi Niu; Zhao-You Tang; Zeng-Chen Ma; Lun-Xiu Qin; Lian-Hai Zhang
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

2.  Invasiveness of hepatocellular carcinoma cell lines: contribution of membrane-type 1 matrix metalloproteinase.

Authors:  K Murakami; R Sakukawa; T Ikeda; T Matsuura; S Hasumura; S Nagamori; Y Yamada; I Saiki
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

3.  Micrometastases of solitary hepatocellular carcinoma and appropriate resection margin.

Authors:  Ming Shi; Chang-Qing Zhang; Ya-Qi Zhang; Xiao-Man Liang; Jin-Qing Li
Journal:  World J Surg       Date:  2004-03-17       Impact factor: 3.352

4.  Efficacy of hepatic resection vs transarterial chemoembolization for solitary huge hepatocellular carcinoma.

Authors:  Shao-Liang Zhu; Jian-Hong Zhong; Yang Ke; Liang Ma; Xue-Mei You; Le-Qun Li
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

5.  Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation.

Authors:  A D Pinna; S Iwatsuki; R G Lee; S Todo; J R Madariaga; J W Marsh; A Casavilla; I Dvorchik; J J Fung; T E Starzl
Journal:  Hepatology       Date:  1997-10       Impact factor: 17.425

Review 6.  Ethanol injection for the treatment of hepatic tumours.

Authors:  C Bartolozzi; R Lencioni
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

7.  Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients.

Authors:  R Tateishi; H Yoshida; S Shiina; H Imamura; K Hasegawa; T Teratani; S Obi; S Sato; Y Koike; T Fujishima; M Makuuchi; M Omata
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

8.  Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre.

Authors:  A Grieco; M Pompili; G Caminiti; L Miele; M Covino; B Alfei; G L Rapaccini; G Gasbarrini
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

9.  Prognostic Factors and Survival Outcomes of Surgical Resection of Huge Hepatocellular Carcinomas.

Authors:  Jayanand Sunil Bhanu; Balasubramanian Venkitaraman; Ravisankar Palaniappan; Rama Ranganathan; Ramakrishnan Ayloor Seshadri; Vikash Mahajan
Journal:  J Gastrointest Cancer       Date:  2020-03

Review 10.  Management of hepatocellular cancer.

Authors:  Mary F Mulcahy
Journal:  Curr Treat Options Oncol       Date:  2005-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.